Literature DB >> 20717507

Loss of heterozygosity at 1p, 7q, 17p, and 22q in meningiomas.

In Bok Chang1, Byung Moon Cho, Seung Myung Moon, Se Hyuck Park, Sae Moon Oh, Seong Jin Cho.   

Abstract

OBJECTIVE: Allelic losses or loss of heterozygosity (LOH) at many chromosomal loci have been found in the cells of meningiomas. The objective of this study was to evaluate LOH at several loci of different chromosomes (1p32, 17p13, 7q21, 7q31, and 22q13) in different grades of meningiomas.
METHODS: Forty surgical specimens were obtained and classified as benign, atypical, and anaplastic meningiomas. After DNA extraction, ten polymorphic microsatellite markers were used to detect LOH. Medical and surgical records, as well as pathologic findings, were reviewed retrospectively.
RESULTS: LOH at 1p32 was detected in 24%, 60%, and 60% in benign, atypical, and anaplastic meningiomas, respectively. Whereas LOH at 7q21 was found in only one atypical meningioma. LOH at 7q31 was found in one benign meningioma and one atypical meningioma. LOH at 17p13 was detected in 4%, 40%, and 80% in benign, atypical, and anaplastic meningiomas, respectively. LOH at 22q13 was seen in 48%, 60%, and 60% in benign, atypical, and anaplastic meningiomas, respectively. LOH results at 1p32 and 17p13 showed statistically significant differences between benign and non-benign meningiomas.
CONCLUSION: LOH at 1p32 and 17p13 showed a strong correlation with tumor progression. On the other hand, LOH at 7q21 and 7q31 may not contribute to the development of the meningiomas.

Entities:  

Keywords:  Chromosome; Loss of heterozygosity; Meningiomas

Year:  2010        PMID: 20717507      PMCID: PMC2916143          DOI: 10.3340/jkns.2010.48.1.14

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


  33 in total

1.  Loss of alkaline phosphatase activity in meningiomas: a rapid histochemical technique indicating progression-associated deletion of a putative tumor suppressor gene on the distal part of the short arm of chromosome 1.

Authors:  I Niedermayer; W Feiden; W Henn; H Steilen-Gimbel; W I Steudel; K D Zang
Journal:  J Neuropathol Exp Neurol       Date:  1997-08       Impact factor: 3.685

2.  Expression patterns of the p53 tumor suppressor gene and the mdm2 proto-oncogene in human meningiomas.

Authors:  M J Pykett; J Landers; D L George
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

3.  Cytological and cytogenetical studies on brain tumors. 4. Identification of the missing G chromosome in human meningiomas as no. 22 by fluorescence technique.

Authors:  H Zankl; K D Zang
Journal:  Humangenetik       Date:  1972

4.  Molecular cloning of a new transforming gene from a chemically transformed human cell line.

Authors:  C S Cooper; M Park; D G Blair; M A Tainsky; K Huebner; C M Croce; G F Vande Woude
Journal:  Nature       Date:  1984 Sep 6-11       Impact factor: 49.962

5.  Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.

Authors:  R G Weber; J Boström; M Wolter; M Baudis; V P Collins; G Reifenberger; P Lichter
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

6.  Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans.

Authors:  T Moriyama; H Kataoka; H Kawano; K Yokogami; S Nakano; T Goya; H Uchino; M Koono; S Wakisaka
Journal:  Cancer Lett       Date:  1998-02-27       Impact factor: 8.679

7.  p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies.

Authors:  E Karamitopoulou; E Perentes; I Diamantis
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network.

Authors:  M Jeffers; S Rong; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

9.  Deletion mapping of the long arm of chromosome 22 in human meningiomas.

Authors:  K Akagi; H Kurahashi; N Arita; T Hayakawa; M Monden; T Mori; S Takai; I Nishisho
Journal:  Int J Cancer       Date:  1995-01-17       Impact factor: 7.396

10.  The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization.

Authors:  Y Liu
Journal:  Gene       Date:  1998-07-17       Impact factor: 3.688

View more
  2 in total

1.  Genomic analysis of synchronous intracranial meningiomas with different histological grades.

Authors:  Tamrin Chowdhury; Yongjin Yoo; Youngbeom Seo; Yun-Sik Dho; Sojin Kim; Anna Choi; Murim Choi; Sung-Hye Park; Chul-Kee Park; Sang Hyung Lee; Ji Yeoun Lee
Journal:  J Neurooncol       Date:  2018-02-08       Impact factor: 4.130

Review 2.  Iodothyronine deiodinases and cancer.

Authors:  A Piekiełko-Witkowska; A Nauman
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.